CD8A and neoplasm: Contrarily, anti-PD-1 Ab treatment did not show any effect on the growth of the B16-OVA tumor in CR-fed-mice (Figure 2B), suggesting CR has a negative effect on the responsiveness to immune checkpoint blockade, presumably through a CD8+ T cell-dependent anti-tumor immune response.